What is 3SMO.PA stock and how does it work?

3SMO.PA stock is GraniteShares 3x Short Moderna, a leveraged daily ETP on EURONEXT that seeks three times the inverse of Moderna (MRNA) returns. It targets daily moves and is unsuitable for long-term buy-and-hold due to compounding and rebalancing effects.

Why did 3SMO.PA stock move sharply today?

The €632.53 close and +9.93% change on 29 Jan 2026 reflect short-term swings in Moderna-related flows and leveraged rebalancing. Low volume (3 shares) means the move occurred on limited liquidity, which can exaggerate percentage changes.

What is Meyka AI’s grade and forecast for 3SMO.PA stock?

Meyka AI rates 3SMO.PA **62.63/100 (Grade: B, Suggestion: HOLD)**. The model projects a base target **€540.00**, bear **€260.00**, and bull **€810.00**. Forecasts are model projections and not guarantees.

Is 3SMO.PA stock suitable for long-term investors?

No. 3SMO.PA is a daily leveraged inverse ETP with path dependency and decay risk. It is designed for short-term tactical trades, not long-term buy-and-hold strategies.

EU Stocks

3SMO.PA up 9.93% to €632.53 on EURONEXT close 29 Jan 2026: short ETP outlook

ByDanny Kontos January 30, 2026

GraniteShares 3x Short Moderna (3SMO.PA stock) closed on EURONEXT at €632.53, up 9.93% on 29 Jan 2026 as markets ended the session. The move made 3SMO.PA one of the larger percentage gainers on the exchange at close, trading between €576.00 and €632.53 intraday. Volume was light at 3 shares versus an average of 29, but the price action pushed the ETP nearer its 50-day average of €442.02, highlighting sharp short-term volatility in this leveraged product. This piece breaks down drivers, technicals, Meyka AI grading and scenario forecasts for traders and investors on EURONEXT in EUR.